Innovation
Keith Kerman, MD is an Operating Partner and Senior Advisor with The Riverside Company, a global private equity firm focused on growth businesses. Dr. Kerman has 20 years of experience in healthcare related private equity, venture capital, and operating roles, and has been an executive, investor, and board member at numerous healthcare businesses and organizations. Prior to joining Riverside, Dr. Kerman was a Managing Director and led the healthcare practice at Primus Capital Funds, a growth equity and middle market buyout firm, and was previously a General Partner with Morgenthaler Ventures. Dr. Kerman also was an operating executive at U.S. Healthcare, where he was president of the company’s subsidiary providing managed care services to self-funded health plans. Prior to joining U.S. Healthcare, he was a Robert Wood Johnson Foundation Clinical Scholar at the University of Pennsylvania, was a member of the clinical faculty at the Hospital of the University of Pennsylvania, and was a Senior Fellow at the Leonard Davis Institute for Health Economics at The Wharton School. He has an AB and an MD from Brown University, and an MBA from The Wharton School of the University of Pennsylvania. Dr. Kerman currently serves on the Board of Directors of AxioMed Spine Corporation, Cleveland Heart Labs, IDOC, and Physicians Pharmacy Alliance. He also serves on the Worldwide Board of Directors of the Healthcare Information Management Systems Society (HIMSS).
Back to Innovation Growth Board